• ExxonMobil (NYSE:XOM) posted fourth quarter earnings of $1.27 a share, beating Zacks of $1.19 a share, versus $1.55 a year ago. The company reported revenues of $89.84 billion
• Humana (NYSE:HUM) posted fourth quarter earnings of $1.48, in-line with Zacks estimates, versus $1.07 on revenues of $7.63 billion, ahead of Zacks estimates of $7.72 billion. The company raised its full-year guidance to $5.15-$5.35
• Morgan Stanley (NYSE:MS) upgraded Comerica (NYSE:CMA) to “overweight,” raising the price target to $45 up from $40
• Barclays (NYSE:BCS) downgraded Mirant (NYSE:MIR) to “underweight,” dropping the price target from $15 to $12
• Deutsche Bank (NYSE:DB) downgraded Macy’s (NYSE:M) to “hold,” with a price target dropped from $26 to $17
• JP Morgan (NYSE:JPM) upgraded Eastman Chemical (NYSE:EMN) to “overweight,” lifting the price target from $60 to $70
• Disney (NYSE:DIS) is reportedly planning sale of its Miramax unit, with an estimated price tag of over $700 million
• Citigroup (NYSE:C) reportedly may sell or spin off its $10 billion Citi Private Equity unit to reduce debt, with reports suggesting its managers are considering purchase of the business
